Apo-CIII (human) LANCE Ultra TR-FRET Detection Kit, 10,000 Assay Points

The LANCE® Ultra Human Apo-CIII Detection Kit is designed for detection and quantitation of ApoC3 in buffered solution and cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

• No-wash steps, no separation steps
• TR-FRET technology
• Sensitive detection
• High reproducibility
• Faster time-to-results
• Easy automation
• 96-well, 384-well, and 1536-well formats

LANCE® and LANCE® (Lanthanide chelate excite) Ultra are our TR-FRET (time-resolved fluorescence resonance energy transfer), homogeneous (no wash) technologies. One antibody of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second molecule is labeled with an acceptor fluorophore (ULight™ dye). Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm.

Apolipoprotein CIII (ApoCIII), a relatively small protein (79 amino acids), is a component of very low density lipoproteins. Apo-CIII delays the catabolism of triglyceride rich particles by inhibiting the activities of lipoprotein lipase, hepatic lipase, and blocks the uptake of triglyceride-rich particles by the cells. Therefore, ApoCIII has been associated with coronary heart disease and diabetes. An increase in ApoCIII levels induces the development of hypertriglyceridemia and associated with non-alcoholic fatty liver disease.